Clinical Trials Browser

Phase 2 × Carcinoma, Small Cell × Temozolomide × Clear all

NCT01900951 2016-01-26

Temozolomide as Maintenance Therapy in Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Small Cell, Small Cell Lung Carcinoma